SCHEMBL24501894

SCHEMBL24501894

CC(C)S(=O)(=O)N1CC[C@@H](N)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.41
JAK2 O60674 2/20 0.38
JAK1 P23458 1/20 0.38
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.33
FAAH O00519 1/20 0.32
PIK3R1 P27986 2/20 0.31
PIK3CA P42336 2/20 0.31
CHRNA7 P36544 1/20 0.31
PDK1 Q15118 1/20 0.30
PDK2 Q15119 1/20 0.30
PDK3 Q15120 1/20 0.30
PDK4 Q16654 1/20 0.30
HRH4 Q9H3N8 1/20 0.30
HRH3 Q9Y5N1 1/20 0.30
PGR P06401 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
MCOLN3 Q8TDD5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15893906 1.00 EPHX2 (0.41) EPHX2JAK2JAK1MEN1KMT2A
Hydrochloric Acid SCHEMBL5221714 0.98 EPHX2 (0.40) EPHX2JAK2JAK1MEN1KMT2A
Hydrochloric Acid SCHEMBL5221768 0.98 EPHX2 (0.40) EPHX2JAK2JAK1MEN1KMT2A
SCHEMBL14136755 0.89 MEN1 (0.41) EPHX2JAK2JAK1MEN1KMT2A
SCHEMBL1517111 0.88 EPHX2 (0.46) EPHX2JAK2JAK1FAAHHRH3
Hydrochloric Acid SCHEMBL5215157 0.86 EPHX2 (0.45) EPHX2JAK2JAK1FAAHHRH3
SCHEMBL19413968 0.82 EPHX2 (0.41) EPHX2JAK2JAK1MEN1KMT2A
SCHEMBL20243572 0.82 EPHX2 (0.41) EPHX2JAK2JAK1MEN1KMT2A
SCHEMBL18251644 0.82 EPHX2 (0.41) EPHX2JAK2JAK1MEN1KMT2A
SCHEMBL10280127 0.78 EPHX2 (0.41) EPHX2JAK2JAK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 WO disclosed